UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 6-K


REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE MONTH OF MAY 2021


COMMISSION FILE NUMBER 001-38976

Genmab A/S
(Exact name of Registrant as specified in its charter)

Kalvebod Brygge 43

1560 Copenhagen V

Denmark

+45 70 20 27 28
(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  Form 40-F 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)

Yes  No 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)

Yes  No 

This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S’s registration statements on Form S-8 (File No. 333-232693) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

nthony

GENMAB A/S

BY:

/s/ Anthony Pagano

Name: Anthony Pagano

Title: Executive Vice President & Chief Financial Officer

DATE: May 10, 2021


EXHIBIT INDEX

O

Exhibit

Description of Exhibit

99.1

Company Announcement Dated May 10, 2021: Transactions in connection with share buy-back program

99.1(a)

Appendix: Transactions May 3-7, 2021


Exhibit 99.1

Graphic

Transactions in connection with share buy-back program

Company Announcement

COPENHAGEN, Denmark; May 10, 2021 – Genmab A/S (Nasdaq: GMAB). On February 23, 2021 Genmab announced the initiation of a share buy-back program to mitigate dilution from warrant exercises and to honor our commitments under our Restricted Stock Units program.

The share buy-back program is expected to be completed no later than June 30, 2021 and comprises up to 200,000 shares.

The following transactions were executed under the program from May 3, 2021 to May 7, 2021:

 

No. of shares

Average price (DKK)

Total value (DKK)

Accumulated through last announcement

128,900

 

268,864,468

April 26, 2021

1,500

2,267.08

3,400,620

April 27, 2021

1,900

2,235.86

4,248,134

April 28, 2021

April 29, 2021

1,800

1,200

2,216.40

2,279.79

3,989,520

2,735,748

April 30, 2021

1,500

2,276.19

3,414,285

Total

7,900

17,788,307

Accumulated under the program

136,800

 

286,652,775

Details of each transaction are included as an appendix to this announcement.

Following these transactions, Genmab holds 236,006 shares as treasury shares, corresponding to 0.36% of the total share capital and voting rights.

The share buy-back program is undertaken in accordance with Regulation (EU) No. 596/2014 (‘MAR’) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the “Safe Harbour Regulation.” Further details on the terms of the share buy-back program can be found in our company announcement no. 11 dated February 23, 2021.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients with cancer. Founded in 1999, Genmab is the creator of multiple approved antibody therapeutics that are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next-generation antibody technologies, expertise in antibody biology, translational research and data sciences and strategic partnerships. To create novel therapies, Genmab utilizes its next-generation antibody technologies, which are the result of its collaborative company culture and a deep passion for innovation. Genmab’s proprietary pipeline consists of modified antibody candidates, including bispecific T-cell engagers and next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. The company is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please visit Genmab.com.

Genmab A/S

Tel: +45 7020 2728

Company Announcement no. 38

Kalvebod Brygge 43

Fax: +45 7020 2729

Page 1/2

21560 Copenhagen V, Denmark

www.genmab.com

CVR no. 2102 3884

LEI Code 529900MTJPDPE4MHJ122


Graphic

Transactions in connection with share buy-back program

Contact:
Marisol Peron, Senior Vice President, Global Investor Relations & Communications

T: +1 609 524 0065; E: mmp@genmab.com

For Investor Relations:

Andrew Carlsen, Vice President, Head of Investor Relations

T: +45 3377 9558; E: acn@genmab.com


This Company Announcement contains forward looking statements. The words “believe”, “expect”, “anticipate”, “intend” and “plan” and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with pre-clinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab’s most recent financial reports, which are available on www.genmab.com and the risk factors included in Genmab’s most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. Genmab does not undertake any obligation to update or revise forward looking statements in this Company Announcement nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law.


Genmab A/S and/or its subsidiaries own the following trademarks: Genmab®; the Y-shaped Genmab logo®; Genmab in combination with the Y-shaped Genmab logo®; HuMax®; DuoBody®; DuoBody in combination with the DuoBody logo®; HexaBody®; HexaBody in combination with the HexaBody logo®; DuoHexaBody®; HexElect®; and UniBody®. Arzerra® and Kesimpta® are trademarks of Novartis AG or its affiliates. DARZALEX® and DARZALEX FASPRO® are trademarks of Janssen Pharmaceutica NV. TEPEZZA® is a trademark of Horizon Therapeutics plc.

Genmab A/S

Tel: +45 7020 2728

Company Announcement no. 38

Kalvebod Brygge 43

Fax: +45 7020 2729

Page 2/2

21560 Copenhagen V, Denmark

www.genmab.com

CVR no. 2102 3884

LEI Code 529900MTJPDPE4MHJ122


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 3-7, 2021

Graphic

Volume

Price

Venue

Time CET

19

2289

XCSE

20210507 9:00:22.609000

19

2273

XCSE

20210507 9:03:39.242000

19

2287

XCSE

20210507 9:06:53.277000

21

2273

XCSE

20210507 9:10:27.615000

19

2271

XCSE

20210507 9:14:58.490000

20

2261

XCSE

20210507 9:19:43.491000

9

2254

XCSE

20210507 9:25:10.888000

10

2254

XCSE

20210507 9:25:10.889000

28

2268

XCSE

20210507 9:33:12.659000

12

2260

XCSE

20210507 9:40:08.393000

7

2260

XCSE

20210507 9:40:19.372000

2

2265

XCSE

20210507 9:48:35.543000

21

2265

XCSE

20210507 9:48:35.543000

20

2266

XCSE

20210507 9:56:59.409000

20

2272

XCSE

20210507 10:04:00.830000

21

2266

XCSE

20210507 10:13:39.805000

25

2272

XCSE

20210507 10:26:26.438000

19

2270

XCSE

20210507 10:32:24.523000

22

2270

XCSE

20210507 10:44:06.462000

19

2262

XCSE

20210507 10:54:00.284000

19

2269

XCSE

20210507 11:06:34.557000

19

2267

XCSE

20210507 11:22:11.680000

3

2264

XCSE

20210507 11:34:40.039000

9

2264

XCSE

20210507 11:35:20.552000

8

2264

XCSE

20210507 11:35:20.552000

19

2262

XCSE

20210507 11:48:17.524000

19

2258

XCSE

20210507 12:00:44.806000

1

2261

XCSE

20210507 12:15:06.081000

18

2261

XCSE

20210507 12:15:06.081000

19

2260

XCSE

20210507 12:32:09.311000

50

2259

XCSE

20210507 12:32:09.311811

19

2261

XCSE

20210507 12:46:11.772000

19

2255

XCSE

20210507 12:59:14.154000

2

2257

XCSE

20210507 13:15:22.085000

17

2257

XCSE

20210507 13:15:22.085000

28

2257

XCSE

20210507 13:36:14.682000

19

2256

XCSE

20210507 13:51:26.273000

19

2254

XCSE

20210507 14:04:07.644000

9

2256

XCSE

20210507 14:22:53.508000

1


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 3-7, 2021

Graphic

10

2256

XCSE

20210507 14:22:53.508000

19

2256

XCSE

20210507 14:25:41.803000

19

2266

XCSE

20210507 14:38:39.948000

1

2265

XCSE

20210507 14:39:58.378000

24

2276

XCSE

20210507 14:57:10.853000

19

2276

XCSE

20210507 14:57:10.853000

19

2274

XCSE

20210507 15:06:26.384000

20

2275

XCSE

20210507 15:16:28.565000

12

2275

XCSE

20210507 15:16:28.565000

10

2275

XCSE

20210507 15:16:28.574000

29

2276

XCSE

20210507 15:21:58.460000

12

2270

XCSE

20210507 15:24:59.677000

19

2270

XCSE

20210507 15:26:23.054000

5

2270

XCSE

20210507 15:27:57.639000

10

2270

XCSE

20210507 15:28:17.826000

24

2276

XCSE

20210507 15:30:54.914000

4

2276

XCSE

20210507 15:30:54.914000

6

2276

XCSE

20210507 15:30:54.914000

19

2276

XCSE

20210507 15:30:54.914000

28

2281

XCSE

20210507 15:34:38.820000

21

2285

XCSE

20210507 15:36:55.267000

22

2287

XCSE

20210507 15:37:51.019000

21

2286

XCSE

20210507 15:43:03.253000

25

2286

XCSE

20210507 15:43:03.253000

10

2284

XCSE

20210507 15:47:28.115000

10

2284

XCSE

20210507 15:47:28.116000

19

2282

XCSE

20210507 15:48:37.697000

10

2281

XCSE

20210507 15:52:10.184000

9

2281

XCSE

20210507 15:52:10.184000

28

2290

XCSE

20210507 15:59:14.166000

20

2290

XCSE

20210507 15:59:14.166000

7

2287

XCSE

20210507 16:02:30.031000

7

2290

XCSE

20210507 16:04:23.708000

22

2290

XCSE

20210507 16:04:39.334000

13

2290

XCSE

20210507 16:04:39.334000

21

2294

XCSE

20210507 16:11:11.126000

25

2294

XCSE

20210507 16:11:11.126000

30

2299

XCSE

20210507 16:48:20.004799

3

2299

XCSE

20210507 16:48:20.004799

30

2299

XCSE

20210507 16:49:06.235554

2


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 3-7, 2021

Graphic

12

2299

XCSE

20210507 16:49:06.235554

8

2299

XCSE

20210507 16:49:06.235554

8

2299

XCSE

20210507 16:50:53.017203

5

2299

XCSE

20210507 16:50:53.017231

17

2299

XCSE

20210507 16:50:53.017231

30

2299

XCSE

20210507 16:50:53.017265

17

2299

XCSE

20210507 16:50:53.017281

25

2299

XCSE

20210507 16:50:53.597798

30

2299

XCSE

20210507 16:50:53.597834

18

2299

XCSE

20210507 16:50:53.597886

24

2330

XCSE

20210506 9:00:01.956000

21

2314

XCSE

20210506 9:02:38.200000

23

2308

XCSE

20210506 9:05:24.161000

10

2307

XCSE

20210506 9:08:07.283000

13

2307

XCSE

20210506 9:08:07.283000

20

2291

XCSE

20210506 9:13:10.162000

19

2294

XCSE

20210506 9:19:53.840000

1

2303

XCSE

20210506 9:25:51.079000

18

2303

XCSE

20210506 9:25:51.079000

8

2301

XCSE

20210506 9:35:36.176000

6

2301

XCSE

20210506 9:35:36.176000

8

2301

XCSE

20210506 9:35:36.176000

22

2298

XCSE

20210506 9:45:45.675000

20

2290

XCSE

20210506 9:57:46.223000

3

2284

XCSE

20210506 10:05:37.746000

16

2284

XCSE

20210506 10:05:37.746000

19

2286

XCSE

20210506 10:16:57.012000

19

2287

XCSE

20210506 10:27:55.634000

19

2272

XCSE

20210506 10:39:05.986000

19

2278

XCSE

20210506 10:54:16.639000

17

2280

XCSE

20210506 11:09:53.604000

2

2280

XCSE

20210506 11:09:53.604000

19

2282

XCSE

20210506 11:24:08.690000

22

2279

XCSE

20210506 11:42:58.944000

19

2279

XCSE

20210506 12:06:03.963000

1

2277

XCSE

20210506 12:06:13.189000

9

2272

XCSE

20210506 12:27:06.007000

10

2272

XCSE

20210506 12:27:06.007000

22

2272

XCSE

20210506 12:27:06.007000

19

2270

XCSE

20210506 12:43:22.247000

3


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 3-7, 2021

Graphic

22

2271

XCSE

20210506 12:51:05.849000

19

2274

XCSE

20210506 13:02:56.219000

24

2279

XCSE

20210506 13:16:37.551000

24

2280

XCSE

20210506 13:27:36.350000

21

2282

XCSE

20210506 13:35:58.500000

1

2282

XCSE

20210506 13:35:58.500000

21

2285

XCSE

20210506 13:49:42.302000

11

2283

XCSE

20210506 13:54:50.280000

8

2283

XCSE

20210506 13:55:00.267000

21

2290

XCSE

20210506 14:08:33.933000

19

2290

XCSE

20210506 14:14:00.254000

4

2286

XCSE

20210506 14:25:48.994000

16

2286

XCSE

20210506 14:26:34.361000

19

2286

XCSE

20210506 14:26:34.382000

5

2272

XCSE

20210506 14:42:25.893000

14

2272

XCSE

20210506 14:42:25.893000

19

2272

XCSE

20210506 14:44:19.956000

19

2273

XCSE

20210506 14:59:06.801000

21

2274

XCSE

20210506 15:04:27.803000

19

2276

XCSE

20210506 15:12:14.192000

12

2275

XCSE

20210506 15:16:20.021000

4

2278

XCSE

20210506 15:26:12.443000

19

2278

XCSE

20210506 15:26:12.443000

34

2278

XCSE

20210506 15:26:12.443000

9

2281

XCSE

20210506 15:30:00.522000

16

2281

XCSE

20210506 15:30:00.523000

13

2281

XCSE

20210506 15:30:00.523000

24

2281

XCSE

20210506 15:30:00.523000

15

2272

XCSE

20210506 15:35:01.673000

4

2272

XCSE

20210506 15:35:01.673000

19

2271

XCSE

20210506 15:35:27.555000

23

2269

XCSE

20210506 15:42:53.441000

20

2269

XCSE

20210506 15:42:53.441000

17

2269

XCSE

20210506 15:51:51.164000

4

2269

XCSE

20210506 15:51:51.164000

26

2271

XCSE

20210506 15:53:22.776000

23

2269

XCSE

20210506 16:01:49.185000

19

2268

XCSE

20210506 16:03:33.212000

20

2264

XCSE

20210506 16:10:08.031000

19

2258

XCSE

20210506 16:11:12.486000

4


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 3-7, 2021

Graphic

1

2253

XCSE

20210506 16:21:50.058912

20

2253

XCSE

20210506 16:21:50.058912

30

2253

XCSE

20210506 16:21:50.058957

14

2253

XCSE

20210506 16:21:50.083602

20

2253

XCSE

20210506 16:21:50.083602

12

2221

XCSE

20210505 9:00:05.337000

14

2221

XCSE

20210505 9:00:05.337000

15

2226

XCSE

20210505 9:03:13.665000

11

2226

XCSE

20210505 9:03:13.665000

20

2212

XCSE

20210505 9:05:50.425000

19

2203

XCSE

20210505 9:07:54.672000

20

2194

XCSE

20210505 9:10:21.764000

31

2194

XCSE

20210505 9:14:41.590000

21

2179

XCSE

20210505 9:18:05.368000

1

2189

XCSE

20210505 9:22:08.058000

4

2189

XCSE

20210505 9:22:09.666000

25

2194

XCSE

20210505 9:23:38.038000

22

2185

XCSE

20210505 9:27:44.157000

16

2183

XCSE

20210505 9:32:30.546000

4

2183

XCSE

20210505 9:32:30.566000

25

2192

XCSE

20210505 9:38:09.577000

8

2208

XCSE

20210505 9:42:45.600000

21

2212

XCSE

20210505 9:44:40.645000

21

2216

XCSE

20210505 9:54:28.681000

16

2216

XCSE

20210505 9:54:28.681000

20

2226

XCSE

20210505 9:59:57.670000

20

2231

XCSE

20210505 10:06:53.913000

20

2224

XCSE

20210505 10:11:46.214000

19

2231

XCSE

20210505 10:17:38.774000

19

2233

XCSE

20210505 10:23:40.636000

2

2228

XCSE

20210505 10:29:10.954000

23

2230

XCSE

20210505 10:31:00.875000

19

2221

XCSE

20210505 10:35:42.563000

22

2227

XCSE

20210505 10:45:01.333000

8

2225

XCSE

20210505 10:54:53.532000

11

2225

XCSE

20210505 10:55:30.082000

19

2220

XCSE

20210505 11:01:44.264000

23

2221

XCSE

20210505 11:08:24.696000

6

2223

XCSE

20210505 11:23:05.750000

18

2223

XCSE

20210505 11:23:05.754000

5


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 3-7, 2021

Graphic

12

2223

XCSE

20210505 11:23:05.754000

23

2218

XCSE

20210505 11:31:02.850000

19

2221

XCSE

20210505 11:40:29.687000

21

2220

XCSE

20210505 11:51:33.738000

25

2226

XCSE

20210505 12:03:48.540000

21

2225

XCSE

20210505 12:15:09.784000

20

2227

XCSE

20210505 12:25:27.862000

19

2222

XCSE

20210505 12:36:22.065000

24

2223

XCSE

20210505 12:48:04.325000

20

2230

XCSE

20210505 12:57:53.622000

2

2222

XCSE

20210505 13:07:53.583000

17

2222

XCSE

20210505 13:07:53.583000

8

2220

XCSE

20210505 13:20:02.909000

11

2220

XCSE

20210505 13:20:02.909000

19

2218

XCSE

20210505 13:28:02.895000

19

2212

XCSE

20210505 13:41:02.848000

12

2216

XCSE

20210505 13:51:02.908000

9

2216

XCSE

20210505 13:51:02.908000

20

2216

XCSE

20210505 13:58:49.557000

30

2214

XCSE

20210505 14:12:51.659000

23

2223

XCSE

20210505 14:22:09.265000

19

2220

XCSE

20210505 14:29:56.080000

19

2216

XCSE

20210505 14:38:39.690000

19

2217

XCSE

20210505 14:47:35.707000

20

2213

XCSE

20210505 14:56:42.000000

19

2211

XCSE

20210505 15:04:09.595000

27

2218

XCSE

20210505 15:13:18.528000

48

2219

XCSE

20210505 15:20:28.231000

2

2220

XCSE

20210505 15:30:44.134000

2

2220

XCSE

20210505 15:30:44.134000

49

2220

XCSE

20210505 15:30:44.134000

30

2220

XCSE

20210505 15:30:44.134000

1

2220

XCSE

20210505 15:30:44.134000

21

2228

XCSE

20210505 15:34:36.081000

19

2225

XCSE

20210505 15:38:26.493000

19

2222

XCSE

20210505 15:41:16.805000

27

2217

XCSE

20210505 15:45:54.604000

19

2215

XCSE

20210505 15:49:54.796000

20

2216

XCSE

20210505 15:53:35.204000

19

2213

XCSE

20210505 15:57:13.165000

6


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 3-7, 2021

Graphic

10

2213

XCSE

20210505 16:01:08.288000

4

2213

XCSE

20210505 16:02:01.147000

4

2213

XCSE

20210505 16:02:01.765000

1

2215

XCSE

20210505 16:03:52.038000

19

2213

XCSE

20210505 16:03:55.637000

24

2212

XCSE

20210505 16:06:38.674000

19

2212

XCSE

20210505 16:07:23.580000

19

2209

XCSE

20210505 16:10:26.762000

6

2209

XCSE

20210505 16:11:15.992000

13

2209

XCSE

20210505 16:11:15.997000

26

2212

XCSE

20210505 16:17:13.650000

25

2212

XCSE

20210505 16:17:13.650000

2

2212

XCSE

20210505 16:21:32.285000

18

2212

XCSE

20210505 16:21:32.317000

20

2219

XCSE

20210505 16:39:08.080775

142

2219

XCSE

20210505 16:39:08.080775

30

2219

XCSE

20210505 16:39:08.080833

10

2219

XCSE

20210505 16:39:10.359540

10

2219

XCSE

20210505 16:39:10.371711

50

2222

XCSE

20210505 16:41:12.378882

18

2276

XCSE

20210504 9:00:39.030000

8

2276

XCSE

20210504 9:00:39.030000

21

2266

XCSE

20210504 9:03:23.726000

17

2266

XCSE

20210504 9:07:41.590000

6

2266

XCSE

20210504 9:07:41.590000

21

2267

XCSE

20210504 9:10:42.250000

26

2267

XCSE

20210504 9:14:06.855000

19

2263

XCSE

20210504 9:17:39.981000

23

2260

XCSE

20210504 9:25:00.576000

20

2258

XCSE

20210504 9:27:36.138000

20

2266

XCSE

20210504 9:33:13.078000

14

2260

XCSE

20210504 9:39:01.871000

5

2260

XCSE

20210504 9:39:01.871000

20

2258

XCSE

20210504 9:43:59.254000

17

2258

XCSE

20210504 9:50:18.763000

2

2258

XCSE

20210504 9:50:18.763000

19

2257

XCSE

20210504 9:56:49.329000

19

2252

XCSE

20210504 10:04:13.196000

21

2248

XCSE

20210504 10:11:35.499000

50

2247

XCSE

20210504 10:12:12.373741

7


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 3-7, 2021

Graphic

21

2245

XCSE

20210504 10:20:55.931000

19

2247

XCSE

20210504 10:27:53.185000

19

2239

XCSE

20210504 10:34:49.899000

10

2239

XCSE

20210504 10:44:03.144000

9

2239

XCSE

20210504 10:44:03.144000

19

2241

XCSE

20210504 10:52:18.982000

19

2231

XCSE

20210504 11:02:14.499000

50

2225

XCSE

20210504 11:03:37.648332

19

2225

XCSE

20210504 11:15:01.387000

23

2225

XCSE

20210504 11:23:17.682000

19

2224

XCSE

20210504 11:32:58.167000

11

2225

XCSE

20210504 11:44:25.512000

10

2225

XCSE

20210504 11:44:25.512000

19

2224

XCSE

20210504 11:59:41.664000

19

2226

XCSE

20210504 12:11:36.536000

9

2222

XCSE

20210504 12:16:48.910308

41

2222

XCSE

20210504 12:16:48.910425

33

2223

XCSE

20210504 12:34:42.902000

19

2223

XCSE

20210504 12:46:28.556000

19

2223

XCSE

20210504 12:58:28.211000

15

2230

XCSE

20210504 13:11:00.841000

4

2230

XCSE

20210504 13:11:00.841000

20

2227

XCSE

20210504 13:24:10.840000

19

2221

XCSE

20210504 13:38:53.063000

19

2214

XCSE

20210504 13:50:25.761000

19

2222

XCSE

20210504 14:03:57.523000

9

2240

XCSE

20210504 14:14:23.578000

12

2240

XCSE

20210504 14:14:23.578000

19

2239

XCSE

20210504 14:24:47.778000

10

2224

XCSE

20210504 14:36:03.870000

10

2224

XCSE

20210504 14:36:55.173000

19

2235

XCSE

20210504 14:47:39.021000

1

2238

XCSE

20210504 14:57:48.074000

19

2239

XCSE

20210504 14:59:20.630000

8

2234

XCSE

20210504 15:07:46.199000

12

2234

XCSE

20210504 15:07:59.832000

19

2237

XCSE

20210504 15:19:02.767000

22

2237

XCSE

20210504 15:19:02.767000

27

2236

XCSE

20210504 15:19:15.339000

20

2232

XCSE

20210504 15:22:14.399000

8


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 3-7, 2021

Graphic

11

2236

XCSE

20210504 15:28:00.311000

7

2236

XCSE

20210504 15:28:00.313000

10

2236

XCSE

20210504 15:28:00.313000

6

2236

XCSE

20210504 15:28:00.313000

5

2236

XCSE

20210504 15:28:00.313000

4

2235

XCSE

20210504 15:28:00.503000

15

2235

XCSE

20210504 15:30:02.078000

21

2239

XCSE

20210504 15:31:36.127000

19

2239

XCSE

20210504 15:31:36.127000

5

2228

XCSE

20210504 15:35:07.364263

15

2228

XCSE

20210504 15:35:07.364292

29

2237

XCSE

20210504 15:37:59.509000

27

2236

XCSE

20210504 15:38:17.711000

22

2234

XCSE

20210504 15:43:36.078000

15

2234

XCSE

20210504 15:43:36.078000

5

2234

XCSE

20210504 15:43:36.078000

24

2233

XCSE

20210504 15:48:20.253000

19

2233

XCSE

20210504 15:48:54.082000

1

2228

XCSE

20210504 15:50:26.076465

2

2228

XCSE

20210504 15:50:26.164325

4

2228

XCSE

20210504 15:50:26.430419

3

2228

XCSE

20210504 15:50:26.518042

10

2228

XCSE

20210504 15:50:52.209640

30

2228

XCSE

20210504 15:50:52.209689

30

2228

XCSE

20210504 15:50:52.209691

20

2225

XCSE

20210504 15:52:58.162000

20

2221

XCSE

20210504 15:56:11.324000

21

2229

XCSE

20210504 16:03:03.914000

23

2228

XCSE

20210504 16:03:23.278000

15

2228

XCSE

20210504 16:03:23.278000

11

2230

XCSE

20210504 16:07:39.428000

9

2230

XCSE

20210504 16:07:40.078000

9

2227

XCSE

20210504 16:10:57.012000

12

2227

XCSE

20210504 16:11:06.832000

30

2228

XCSE

20210504 16:12:17.582039

30

2228

XCSE

20210504 16:12:17.582039

20

2228

XCSE

20210504 16:12:17.582039

20

2228

XCSE

20210504 16:12:17.582039

36

2228

XCSE

20210504 16:12:57.934000

29

2231

XCSE

20210504 16:15:58.652000

9


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 3-7, 2021

Graphic

19

2231

XCSE

20210504 16:15:58.652000

22

2234

XCSE

20210504 16:22:13.771000

5

2232

XCSE

20210504 16:25:21.767000

14

2232

XCSE

20210504 16:25:21.768000

27

2231

XCSE

20210504 16:30:06.201000

19

2226

XCSE

20210504 16:35:08.208000

20

2227

XCSE

20210504 16:36:27.791484

15

2227

XCSE

20210504 16:36:27.791515

20

2227

XCSE

20210504 16:36:27.791518

19

2227

XCSE

20210504 16:36:27.791535

20

2283

XCSE

20210503 9:00:24.532000

22

2285

XCSE

20210503 9:04:17.451000

25

2275

XCSE

20210503 9:08:06.153000

12

2278

XCSE

20210503 9:11:56.740000

8

2278

XCSE

20210503 9:11:56.740000

8

2275

XCSE

20210503 9:16:38.461000

13

2275

XCSE

20210503 9:16:38.461000

19

2282

XCSE

20210503 9:21:49.741000

28

2287

XCSE

20210503 9:30:00.050000

31

2288

XCSE

20210503 9:40:04.019000

15

2290

XCSE

20210503 9:48:12.516000

5

2290

XCSE

20210503 9:48:12.516000

20

2282

XCSE

20210503 9:55:50.247000

19

2279

XCSE

20210503 10:06:47.379000

19

2277

XCSE

20210503 10:13:12.046000

19

2278

XCSE

20210503 10:23:33.099000

3

2273

XCSE

20210503 10:30:58.955000

28

2277

XCSE

20210503 10:36:21.383000

20

2280

XCSE

20210503 10:50:11.212000

19

2276

XCSE

20210503 11:02:01.908000

19

2272

XCSE

20210503 11:15:02.054000

19

2271

XCSE

20210503 11:22:34.593000

19

2266

XCSE

20210503 11:32:31.500000

4

2262

XCSE

20210503 11:38:48.968429

46

2262

XCSE

20210503 11:38:48.968471

11

2267

XCSE

20210503 11:56:02.918000

22

2267

XCSE

20210503 11:56:02.918000

20

2269

XCSE

20210503 12:11:04.278000

22

2268

XCSE

20210503 12:29:04.416000

19

2260

XCSE

20210503 12:46:55.076000

10


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 3-7, 2021

Graphic

17

2264

XCSE

20210503 12:59:21.045000

2

2264

XCSE

20210503 12:59:21.045000

20

2263

XCSE

20210503 13:17:18.928000

19

2264

XCSE

20210503 13:29:21.296000

31

2268

XCSE

20210503 13:55:03.042000

19

2266

XCSE

20210503 14:09:09.821000

19

2265

XCSE

20210503 14:21:47.558000

15

2264

XCSE

20210503 14:30:56.112143

30

2264

XCSE

20210503 14:30:56.112204

19

2264

XCSE

20210503 14:35:07.093000

15

2264

XCSE

20210503 14:35:07.093409

1

2264

XCSE

20210503 14:35:07.093455

14

2264

XCSE

20210503 14:35:07.093508

20

2267

XCSE

20210503 14:54:36.522000

30

2267

XCSE

20210503 15:05:48.912000

27

2276

XCSE

20210503 15:16:20.928000

1

2275

XCSE

20210503 15:22:32.006000

19

2274

XCSE

20210503 15:24:19.269000

24

2273

XCSE

20210503 15:26:01.558000

20

2273

XCSE

20210503 15:28:00.197000

8

2267

XCSE

20210503 15:28:09.282000

12

2267

XCSE

20210503 15:28:09.282000

23

2262

XCSE

20210503 15:31:09.509798

2

2262

XCSE

20210503 15:31:09.510024

6

2262

XCSE

20210503 15:31:09.510231

17

2262

XCSE

20210503 15:31:09.510390

2

2262

XCSE

20210503 15:31:09.532344

25

2262

XCSE

20210503 15:31:09.532344

8

2262

XCSE

20210503 15:31:47.163000

12

2262

XCSE

20210503 15:31:47.163000

20

2260

XCSE

20210503 15:32:41.793000

10

2260

XCSE

20210503 15:35:12.930000

9

2260

XCSE

20210503 15:35:14.684000

10

2254

XCSE

20210503 15:37:37.345000

8

2254

XCSE

20210503 15:37:49.459000

19

2258

XCSE

20210503 15:38:33.227000

15

2250

XCSE

20210503 15:44:26.209000

10

2250

XCSE

20210503 15:44:26.214000

2

2250

XCSE

20210503 15:45:12.246000

4

2250

XCSE

20210503 15:45:12.943000

11


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 3-7, 2021

Graphic

1

2250

XCSE

20210503 15:45:13.944000

3

2250

XCSE

20210503 15:45:14.031000

1

2250

XCSE

20210503 15:45:44.078000

8

2250

XCSE

20210503 15:45:45.080000

21

2254

XCSE

20210503 15:48:29.251000

20

2253

XCSE

20210503 15:48:59.992000

15

2255

XCSE

20210503 15:54:59.022000

7

2255

XCSE

20210503 15:54:59.022000

10

2254

XCSE

20210503 15:55:21.828000

10

2254

XCSE

20210503 15:55:24.829000

11

2255

XCSE

20210503 15:59:17.215000

8

2255

XCSE

20210503 15:59:17.215000

22

2252

XCSE

20210503 16:01:28.758000

19

2249

XCSE

20210503 16:03:39.780000

21

2260

XCSE

20210503 16:08:09.412000

2

2258

XCSE

20210503 16:09:37.644000

13

2258

XCSE

20210503 16:09:37.782000

19

2267

XCSE

20210503 16:16:26.478000

2

2267

XCSE

20210503 16:16:26.478000

27

2267

XCSE

20210503 16:16:26.478000

19

2265

XCSE

20210503 16:22:40.884000

19

2264

XCSE

20210503 16:26:53.147000

5

2262

XCSE

20210503 16:29:14.723000

14

2262

XCSE

20210503 16:29:14.723000

1

2262

XCSE

20210503 16:36:54.142000

13

2262

XCSE

20210503 16:37:09.538000

51

2260

XCSE

20210503 16:38:13.980582

12